|
Index of reports
> Cases resulting in a serious event (70)
> Cases with Breast Cancer Female (15)
Below is the selection of adverse event reports related to Estrace (Estradiol Vaginal) that includes cases resulting in a serious event where reactions include breast cancer female.
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a lawyer from United States on 2007-07-31
Patient: female
Adverse reactions / side effects: Breast Cancer Female
Adverse event resulted in: death
Suspect drug(s):
Provera
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1995-01-01
End date: 2000-01-01
Premarin
Indication: Menopausal Symptoms
Start date: 1995-01-01
End date: 2000-01-01
Estratest
Indication: Menopausal Symptoms
Start date: 1995-01-01
End date: 2000-01-01
Estrace
Indication: Menopausal Symptoms
Start date: 1995-01-01
End date: 2000-01-01
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a lawyer from United States on 2007-06-12
Patient: female
Adverse reactions / side effects: Breast Cancer Female
Suspect drug(s):
Medroxyprogesterone Acetate(medroxyprogesterone Acetate(medroxyprogest
Dosage: oral
Administration route: Oral
Estradiol
Dosage: oral
Administration route: Oral
Cycrin
Dosage: oral
Administration route: Oral
Estrace
Dosage: oral
Administration route: Oral
Estratest
Dosage: oral
Administration route: Oral
Premarin
Dosage: oral
Administration route: Oral
Prempro
Dosage: oral
Administration route: Oral
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a lawyer from United States on 2007-05-11
Patient: female
Adverse reactions / side effects: Breast Cancer Female
Suspect drug(s):
Medroxyprogesterone
Dosage: oral
Administration route: Oral
Start date: 1990-01-01
End date: 2001-06-01
Estradiol
Dosage: oral
Administration route: Oral
Start date: 1990-01-01
End date: 2001-06-01
Estrace
Dosage: oral
Administration route: Oral
Start date: 1990-01-01
End date: 2001-06-01
Premarin
Dosage: oral
Administration route: Oral
Start date: 1990-01-01
End date: 2001-06-01
Provera
Dosage: oral
Administration route: Oral
Start date: 1990-01-01
End date: 2001-06-01
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a lawyer from United States on 2007-05-08
Patient: female
Adverse reactions / side effects: Breast Cancer Female
Suspect drug(s):
Provera
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1990-01-01
End date: 2001-06-01
Medroxyprogesterone Acetate
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1990-01-01
End date: 2001-06-01
Premarin
Indication: Hormone Replacement Therapy
Start date: 1990-01-01
End date: 2001-06-01
Estradiol
Indication: Hormone Replacement Therapy
Start date: 1990-01-01
End date: 2001-06-01
Estrace
Indication: Hormone Replacement Therapy
Start date: 1990-01-01
End date: 2001-06-01
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a lawyer from United States on 2007-03-16
Patient: female
Adverse reactions / side effects: Breast Cancer Female
Suspect drug(s):
Provera
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1998-01-01
End date: 2003-04-01
Medroxyprogesterone Acetate
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1998-01-01
End date: 2003-04-01
Estrace
Indication: Hormone Replacement Therapy
Start date: 1998-01-01
End date: 2003-04-01
Estradiol
Indication: Hormone Replacement Therapy
Start date: 1998-01-01
End date: 2003-04-01
Cycrin
Indication: Hormone Replacement Therapy
Start date: 1998-01-01
End date: 2003-04-01
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a lawyer from United States on 2007-03-16
Patient: female
Adverse reactions / side effects: Breast Cancer Female
Suspect drug(s):
Provera
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1998-01-01
End date: 2003-01-01
Activella
Indication: Hormone Replacement Therapy
Start date: 1998-01-01
End date: 2003-01-01
Estrace
Indication: Hormone Replacement Therapy
Start date: 1998-01-01
End date: 2003-01-01
Adverse event in 58 year old female receiving Estrace (Estradiol Vaginal)
Reported by a physician from United States on 2007-03-15
Patient: 58 year old female
Adverse reactions / side effects: Pulmonary Hypertension, Biopsy Breast Abnormal, Diabetes Mellitus, Dilatation Ventricular, Tricuspid Valve Incompetence, Treatment Noncompliance, Surgery, Atrial Hypertrophy, Oedema Peripheral, Breast Hyperplasia, Echocardiogram, Back Pain, Supraventricular Tachycardia, Breast Cancer Female, Cholelithiasis, Ventricular Dysfunction, Cholecystectomy, Homicidal Ideation, Scan Myocardial Perfusion Abnormal, Head Injury, Breast Cancer Stage IV, Pain, Hemiparesis, Fall, Fatigue, Fibrocystic Breast Disease, Coronary Artery Bypass, Dizziness, Lymphoedema, Atrial Flutter, Urinary Tract Infection, Atrial Fibrillation, Cerebrovascular Accident, Cardiac Pacemaker Insertion, Arthralgia, Mitral Valve Incompetence, Infarction
Adverse event resulted in: hospitalization
Suspect drug(s):
Vivelle
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 1995-01-01
Premarin
Dosage: 10 mg, unk
Administration route: Oral
End date: 1996-08-01
Provera
Dosage: 0.625 mg, unk
Administration route: Oral
End date: 1996-08-01
Cycrin
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 1995-01-01
Curretab
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 1995-01-01
Estrace
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 1995-01-01
MPA
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 1995-01-01
Estratest
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 1995-01-01
Prempro
Dosage: 0.625/25 mg, unk
Indication: Hormone Replacement Therapy
Start date: 1996-08-01
End date: 2002-08-01
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a lawyer from United States on 2007-03-09
Patient: female
Adverse reactions / side effects: Breast Cancer Female
Suspect drug(s):
Medroxyprogesterone
Dosage: oral
Administration route: Oral
Start date: 1998-01-01
End date: 2003-04-01
Estradiol
Dosage: oral
Administration route: Oral
Start date: 1998-01-01
End date: 2003-04-01
Cycrin
Dosage: oral
Administration route: Oral
Start date: 1998-01-01
End date: 2003-04-01
Estrace
Dosage: oral
Administration route: Oral
Start date: 1998-01-01
End date: 2003-04-01
Provera
Dosage: oral
Administration route: Oral
Start date: 1998-01-01
End date: 2003-04-01
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a lawyer from United States on 2007-03-07
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic, Breast Cancer Female
Adverse event resulted in: death
Suspect drug(s):
Estradiol
Dosage: oral
Administration route: Oral
Start date: 1985-01-01
End date: 1999-01-01
Premarin
Dosage: oral
Administration route: Oral
Start date: 1985-01-01
End date: 1995-01-01
Estrace
Dosage: oral
Administration route: Oral
Start date: 1985-01-01
End date: 1999-01-01
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a individual with unspecified qualification from United States on 2007-02-23
Patient: female
Adverse reactions / side effects: Breast Cancer Female
Suspect drug(s):
Medroxyprogesterone
Dosage: oral
Administration route: Oral
Start date: 1996-12-01
End date: 2001-03-01
Estradiol
Dosage: oral
Administration route: Oral
Start date: 1996-12-01
End date: 2001-03-01
Estrace
Dosage: oral
Administration route: Oral
Start date: 1996-12-01
End date: 2001-03-01
Estratab
Dosage: oral
Administration route: Oral
Start date: 1996-12-01
End date: 2001-03-01
Prometrium
Dosage: oral
Administration route: Oral
Start date: 1996-12-01
End date: 2001-03-01
Provera
Dosage: oral
Administration route: Oral
Start date: 1996-12-01
End date: 2001-03-01
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a lawyer from United States on 2007-02-22
Patient: female
Adverse reactions / side effects: Breast Cancer Female
Suspect drug(s):
Provera
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1996-12-01
End date: 2001-03-01
Medroxyprogesterone Acetate
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1996-12-01
End date: 2001-03-01
Estrace
Indication: Hormone Replacement Therapy
Start date: 1996-12-01
End date: 2001-03-01
Estradiol
Indication: Hormone Replacement Therapy
Start date: 1996-12-01
End date: 2001-03-01
Prometrium
Indication: Hormone Replacement Therapy
Start date: 1996-12-01
End date: 2001-03-01
Estratab
Indication: Hormone Replacement Therapy
Start date: 1996-12-01
End date: 2001-03-01
Adverse event in 59 year old female receiving Estrace (Estradiol Vaginal)
Reported by a lawyer from United States on 2007-02-21
Patient: 59 year old female, weighing 70.7 kg (155.5 pounds)
Adverse reactions / side effects: Breast Cancer Female
Suspect drug(s):
Climara
Dosage: 0.05 mg/d, cont, transdermal
Indication: Menopausal Symptoms
Start date: 1997-01-01
End date: 1998-01-01
Premarin
Dosage: 0.625 mg
Indication: Menopausal Symptoms
Start date: 1991-01-01
End date: 1994-01-01
Ogen
Dosage: 1.25 mg
Indication: Menopausal Symptoms
Start date: 1991-01-01
End date: 1991-01-01
Provera
Dosage: 10 mg
Indication: Menopausal Symptoms
Start date: 1991-01-01
Estratest
Indication: Menopausal Symptoms
Start date: 1991-01-01
End date: 1992-01-01
Estrace
Dosage: 1 mg
Indication: Menopausal Symptoms
Start date: 1992-01-01
End date: 1997-01-01
Medroxyprogesterone
Dosage: 10 g
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 1995-01-01
Activella
Indication: Menopausal Symptoms
Start date: 2000-01-01
End date: 2001-01-01
Prempro
Indication: Menopausal Symptoms
Menest
Dosage: 3 mg
Indication: Menopausal Symptoms
Start date: 1999-01-01
End date: 2000-01-01
Estratab
Dosage: 3 mg
Indication: Menopausal Symptoms
Start date: 1998-01-01
End date: 1999-01-01
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a lawyer from United States on 2007-01-30
Patient: female
Adverse reactions / side effects: Breast Cancer Female
Suspect drug(s):
Medroxyprogesterone
Dosage: oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 1989-01-01
End date: 2001-02-01
Estradiol
Dosage: oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 1989-01-01
End date: 2001-02-01
Cycrin
Dosage: oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 1989-01-01
End date: 2001-02-01
Estrace
Dosage: oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 1989-01-01
End date: 2001-02-01
Estratest
Dosage: oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 1989-01-01
End date: 2001-02-01
Premarin
Dosage: oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 1989-01-01
End date: 2001-02-01
Prempro
Dosage: oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 1989-01-01
End date: 2001-02-01
Provera
Dosage: oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 1989-01-01
End date: 2001-02-01
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a lawyer on 2007-01-29
Patient: female
Adverse reactions / side effects: Breast Cancer Female
Suspect drug(s):
Provera
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1989-01-01
End date: 2001-02-01
Medroxyprogesterone Acetate Tablet
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1989-01-01
End date: 2001-02-01
Premarin
Indication: Hormone Replacement Therapy
Start date: 1989-01-01
End date: 2001-02-01
Prempro
Indication: Hormone Replacement Therapy
Start date: 1989-01-01
End date: 2001-02-01
Cycrin
Indication: Hormone Replacement Therapy
Start date: 1989-01-01
End date: 2001-02-01
Estratest
Indication: Hormone Replacement Therapy
Start date: 1989-01-01
End date: 2001-02-01
Estradiol
Indication: Hormone Replacement Therapy
Start date: 1989-01-01
End date: 2001-02-01
Estrace
Indication: Hormone Replacement Therapy
Start date: 1989-01-01
End date: 2001-02-01
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a lawyer from United States on 2007-01-12
Patient: female
Adverse reactions / side effects: Breast Cancer Female
Suspect drug(s):
Provera
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1989-01-01
End date: 2001-01-01
Premarin
Indication: Hormone Replacement Therapy
Start date: 1989-01-01
End date: 2001-01-01
Estrace
Indication: Hormone Replacement Therapy
Start date: 1989-01-01
End date: 2001-01-01
Prempro
Indication: Hormone Replacement Therapy
Start date: 1989-01-01
End date: 2001-01-01
|
